Here we will begin to look at B cells and Antibodies.
1/ Immunoglobulin means “Immune Protein”. This is what we call the proteins produced by the B cells. When these immunoglobulins are embedded into the B cell membrane, they are called the B cell receptor (BCR).
2/ When they are secreted out of the mature B cell, they are called Immunoglobulins or antibodies. The term Immunoglobulin is abbreviated as Ig.
3/ Antibodies are made up of four separate proteins connected by flexible disulfide bonds. They look a lot like a Y. They contain two long protein chains called the heavy chains.
4/ These heavy chains will change as the immune response progresses in a process called class switching. The other two chains are called the light chains.
5/ At the tip of each chain, there are the antigen binding sites which are called the Function Antigen Binding (FAB) region of the antibody. This is the unique part of the antibody that binds to a pathogen.
6/ The rest of the antibody structure is called the Fragment Crystallizable (Fc) region. This is the section of the antibody that interacts with other cells of the immune system. The Fc portion of the antibody is covered up when it is not bound to an antigen.
7/ B cells are born in the bone marrow. They are first called Pro-B cells as they select to go down the development path to become fully mature B cells. The only thing they will have is the Immunoglobulin alpha and beta chains that act as the co-receptors for the B cell receptor.
8/ These Ig-a and Ig-b are the exact same for every B cell. They are the first part of the B cell receptor complex. The first thing that will occur will be the recombination of the Heavy chain. We covered the process of recombination.
9/ The heavy chain will pick one of each VDJ genes and make the heavy chain's variable region. Once the variable region of the heavy chain is created, it will be attached to the constant region. The heavy chain can use two different constant regions from IgM and IgD.
10/ The difference between the two is just splice variants. That means equal amounts of both IgM and IgD isotypes will be expressed on that B cell with the exact same antigen binding region.
11/ Then the B cell will express these heavy chains on its surface with surrogate light chains. The surrogate light chains are just placeholders to ensure the B cell can express a B cell receptor.
12/ Once that test is good, the B cell moves into the Pre-B cell stage. They will pull the receptors back in so they can do recombination with the VJ genes of the light chains.
13/ There are two possible light chains with Lambda and Kappa. The B cell will try to make one good light chain. If that one fails, then it will try to form the other light chain.
14/ You usually end up with equal amounts of B cells having each type light chain. The 2 light chains actually have their own set of genes on different chromosomes with Kappa on chromosome 2 and Lambda on chromosome 22.
15/ Once the B cell receptor is fully constructed, it will be expressed on the cell surface and it will become an immature B cell. All B cell receptors are tested against self antigens in the bone marrow before they leave.
16/ This prevents self reactive B cells from getting into circulation. This process is not as extensive as with T cells. There are no special cells here expressing all proteins with the AIRE. They just get checked for whatever antigens are in the bone marrow.
17/ Any B cells that are self reactive will be allowed to try to make a new receptor with their remaining gene segments. If they continue to fail, that B cell will undergo programmed cell death. This is called Central Tolerance.
18/ The immature B cell will leave the bone marrow and move into circulation. They will travel to the lymph nodes where they will assume their duties. They will act as both Antigen Presenting cells looking for antigens and Effector cells when they activate to become plasma cells.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Here we will look more into the T cell receptor creation.
1/ The T cell will begin the arrangement of its Beta chain of the T cell receptor. This works in a competitive environment as both sets of genes from mom and dad compete to see which one is able to rearrange a successful Beta chain first.
2/ The genes for the Beta chain are located on chromosome 7. They are divided into 3 categories of the Variable genes, the Diversity genes and the Joining genes.
I have done many threads on Recursion and the potentially game changing technology behind the company. This thread will be to look at the actual company.
1/ The first thing is the pipeline. They have 3 programs that they in licensed which are all in phase 2. They have multiple programs going now from their Recursion OS.
2/ They have 2 major partnerships the big one is for Roche which they can do up to 40 programs with each program worth upward of $300 million in milestones. All in, I think its about $12.5 billion in biobucks.
Taking a look at @InSilicoMeds which is a software company in the #tebhbio space. They appear to be similar to @AtomwiseInc. They are building #AI, #MachineLearning, and #DeepLearning software tools for all stages of drug discovery..
1/ They are not just developing a single platform. They have 3 platforms which are designed for different roles in drug discovery process.
2/ They are already using these platforms to develop a pipeline. They have a ton of programs in discovery.
Taking a look at @AtomwiseInc which is a software company in the #tebhbio space. They appear to be similar to Schrodinger. They are building #AI, #MachineLearning, and #DeepLearning software for modeling proteins and small molecule interactions.
1/ One of the major problems with proteins in understanding how the protein and small molecule drug interact. #AtomNet is their software platform that is being developed and trained on modeling and predicting the protein and drug interaction.
2/ They are using their platform do focus on drug development which I love so much more than Schrodinger. They already have a pipeline of a few targets like Tyk2.
A look at the #science behind $ABSI. This company is in the #techbio space. They are combining #synbio, #MachineLearning and #generativeAI to take on a new approach to antibody discovery.
1/ They start with #synbio using their #SoluPro platform which takes Ecoli and uses it to create humanized proteins. This can be used to produce both antigen proteins and antibody proteins.
2/ From my understanding, they are using the SoluPro to produce both antibody and proteins with tags on them. They then run a massive "speed dating" like assay where the proteins and antibodies are put together to see how they respond. Maybe @SeanRMcClain can correct me on this.